Director pay rises across ASX healthcare sector, but gender balance remains uneven

Remuneration for board directors in Australia’s listed healthcare and biotechnology sector increased materially in the financial year 2025, with growth driven largely by the expanding use of equity-based incentives rather than increases in base fees. …